Elizabeth Hayes, Portland Business Journal
The Wayne D. Kuni & Joan E. Kuni Foundation has awarded $5 million to Legacy Health Foundation to found a cancer research project.
The grant, the largest the Foundation has collected, will fund research into how cancer can be targeted by manipulating adenosine kinase, an enzyme that controls cell growth.
The research is led by Detlev Boison, Dow Chair of Neurology and director of neurobiology research and basic and translational research at Legacy Research Institute; and Dr. Serene Perkins, director of surgical and clinical research at Legacy Research Institute, which is part of Portland-based Legacy Health. Read the rest at the Portland Business Journal.